EQRx, Inc. Common Stock (EQRX)

EQRX was delisted on the 8th of November, 2023.

• Market cap: $1.14B
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: EQRx Inc is a biotechnology company. the company has more than 10 programs in its pipeline, including clinical, preclinical and drug engineering targets for the treatment of oncology and immune-inflammatory conditions. The program includes Aumolertinib, Lerociclib, Sugemalimab, Nofazinlimab, and others.

Employees: 363